Table 1. Baseline characteristics of sex, age and cardiometabolic risk factors in the following 4 groups: 1) subjects with none of the cardiometabolic risk factors (N4RF_NO; n = 20), 2) subjects with only central obesity without the other 4 MetS cardiometabolic risk factors (N4RF_O; n = 35), 3) subjects without central obesity but with the other 4 MetS cardiometabolic risk factors (4RF_NO; n = 9), and 4) subjects with all five MetS cardiometabolic risk factors (4RF_O; n = 19).
Data are expressed as mean ± standard deviation. Statistical significance was accepted at P < 0.05.
| Group 1 (N4RF_NO) N = 20 |
Group 2 (N4RF_O) N = 35 |
Group 3 (4RF_NO) N = 9 |
Group 4 (4RF_O) N = 19 |
P value | ||
|---|---|---|---|---|---|---|
| Gender | 17 Females 3 Males |
19 Females 6 Males |
5 Females 4 Males |
21 Females 7 Males |
0.402 | |
| Age (Years) | 62 ± 6 | 58 ± 11 | 65 ± 5 | 65 ± 11 | 0.135 | |
| Group 1 | Group 2 | Group 3 | Group 4 | Group Comparisons | ||
|
Diastolic blood pressure (mmHg) |
71.5 ± 7 | 71.5 ± 6 | 82.4 ± 9 | 83.9 ± 12.5 | ||
|
Systolic blood pressure (mmHg) |
123 ± 7.7 | 122 ± 6.3 | 170.2 ± 11.2 | 159 ± 17.2 | ||
| 1–3 | <0.05 | |||||
| 1–4 | <0.05 | |||||
|
Fasting glucose (mmol/L) |
4.9 ± 0.4 | 5.1 ± 0.3 | 6.3 ± 0.8 | 6.8 ± 1.3 | 2–3 | <0.05 |
|
Blood triglycerides (mmol/L) |
0.9 ± 0.3 | 1.1 ± 0.3 | 2.1 ± 0.4 | 2.5 ± 1.0 | 2–4 | <0.05 |
|
Blood high density lipoprotein cholesterol (mmol/L) |
1.8 ± 0.4 | 1.7 ± 0.3 | 1.0 ± 0.2 | 1.0 ± 0.2 | ||
|
Waist circumference (cm) |
72.9 ± 7 | 86.6 ± 5 | 80.6 ± 4.5 | 92.6 ± 10.2 | 1–2 | <0.05 |
| 1–4 | <0.05 | |||||
| 2–3 | <0.05 | |||||
| 2–4 | <0.05 |